Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam17 Regulatory News (TM17)

Share Price Information for Team17 (TM17)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 275.00
Bid: 270.00
Ask: 280.00
Change: 2.00 (0.75%)
Spread: 10.00 (3.704%)
Open: 270.00
High: 267.00
Low: 267.00
Prev. Close: 265.00
TM17 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Genesis Alpha One Launch

7 Dec 2018 07:00

RNS Number : 7369J
Team17 Group PLC
07 December 2018
 

7 December 2018

Team17 Group plc

("Team17", the "Group" or the "Company")

 

Announcement of Genesis Alpha One Launch

 

- Genesis Alpha One for PC to launch exclusively on recently launched Epic Games Store

- Game will simultaneously launch on PlayStation 4 and Xbox One

 

Team17, a global games label, creative partner and developer of independent ("indie"), premium video games, is pleased to announce that Genesis Alpha One will launch on 29 January 2019 and is available immediately for pre-order.

 

The announcement of the launch of Genesis Alpha One was made at The Game Awards, the flagship awards ceremony for the gaming industry, held yesterday in Los Angeles.

 

The game will launch on PlayStation 4, Xbox One and on PC exclusively via the recently launched Epic Games store. The Epic Games store is a new digital distribution platform selling to PC gamers, which offers developers 88% of revenues from games sales.

 

The game has been co-developed with German-based independent games developer, Radiation Blue. Genesis Alpha One is a sci-fi roguelike first-person shooter game, which puts the player in the role of an interstellar pioneer, on the ultimate mission to save the human species from extinction.

 

Debbie Bestwick MBE, Chief Executive Officer of Team17, commented:

 

"We are delighted today to announce the launch of Genesis Alpha One. The collaboration with Radiation Blue demonstrates our capabilities in partnering with international games developers to bring high quality games to market.

 

"We have had a relationship with Epic since 1991 and are very supportive of their new platform. We are therefore pleased to be launching the PC version exclusively on the Epic platform, which offers significant opportunities for both developers and gamers alike."

 

 

Enquiries:

 

Team17 Group plc

Debbie Bestwick MBE, Chief Executive Officer

Jo Jones, Chief Financial Officer

 

via Vigo Communications

+44 (0)20 7390 0238

GCA Altium (Nominated Adviser)

Phil Adams / Adrian Reed / Paul Lines

 

+44 (0)845 505 4343

Berenberg (Broker)

Chris Bowman / Toby Flaux / Marie-Agnes Stolberg

 

+44 (0)20 3207 7800

Vigo Communications (Financial Public Relations)

Jeremy Garcia / Fiona Henson / Charlie Neish

team17@vigocomms.com

+44 (0)20 7390 0238

 

 

 

About Team17

 

Founded in 1990, Team17 Group plc is a leading international video games label and creative partner for independent developers. The portfolio comprises over 100 games, including The Escapists, Genesis Alpha One, Overcooked, Yoku's Island Express, Yooka-Laylee, the Worms franchise and many more from developers around the world. Visit www.team17.com for more info.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRATFBRTMBMMBPP
Date   Source Headline
13th Mar 20239:05 amRNSNo Material Exposure to Silicon Valley Bank
2nd Mar 20237:00 amRNSNotice of Results & Analyst/Investor Presentations
13th Feb 20231:41 pmRNSDirector/PDMR Shareholding
31st Jan 20232:40 pmRNSHoldings in Company
19th Jan 20235:20 pmRNSHolding(s) in Company
18th Jan 20237:00 amRNSTrading Update
12th Jan 20239:04 amRNSDirector/PDMR Shareholding
10th Jan 20236:19 pmRNSHolding(s) in Company
9th Jan 20232:48 pmRNSTrading Update
13th Dec 20223:51 pmRNSDirector/PDMR Shareholding
17th Nov 20228:46 amRNSHolding(s) in Company
11th Nov 20225:13 pmRNSDirector/PDMR Shareholding
20th Oct 202212:11 pmRNSHolding(s) in Company
18th Oct 20221:42 pmRNSDirector/PDMR Shareholding
13th Sep 20224:32 pmRNSDirector/PDMR Shareholding
13th Sep 20227:00 amRNSHalf Year Results
5th Sep 20227:00 amRNSNotice of Results & Analyst/Investor presentations
12th Aug 20221:29 pmRNSDirector/PDMR Shareholding
18th Jul 20225:08 pmRNSHolding(s) in Company
15th Jul 20223:25 pmRNSHolding(s) in Company
14th Jul 20227:00 amRNSTrading Update
12th Jul 20223:56 pmRNSDirector/PDMR Shareholding
30th Jun 20223:58 pmRNSGrant of Options to Directors / PDMRs
29th Jun 20224:39 pmRNSResult of AGM
15th Jun 20227:00 amRNSDirector/PDMR Shareholding
14th Jun 20221:26 pmRNSHolding(s) in Company
1st Jun 202212:00 pmRNSPosting of Annual Report and Notice of AGM
20th May 20221:28 pmRNSDirector/PDMR Shareholding
17th May 20221:22 pmRNSDirector / PDMR Shareholding & Total Voting Rights
11th May 20225:36 pmRNSDirector/PDMR Shareholding
12th Apr 20225:48 pmRNSDirector/PDMR Shareholding
5th Apr 202211:06 amRNSSecond Price Monitoring Extn
5th Apr 202211:00 amRNSPrice Monitoring Extension
30th Mar 20227:00 amRNSUnaudited Final Results
28th Mar 20224:40 pmRNSSecond Price Monitoring Extn
28th Mar 20224:35 pmRNSPrice Monitoring Extension
28th Mar 20227:00 amRNSInvestor / Analyst call
11th Mar 20223:19 pmRNSDirector/PDMR Shareholding
8th Mar 20224:41 pmRNSSecond Price Monitoring Extn
8th Mar 20224:36 pmRNSPrice Monitoring Extension
1st Mar 20227:00 amRNSNotice of Results
14th Feb 20223:59 pmRNSHolding(s) in Company
11th Feb 20222:21 pmRNSDirector/PDMR Shareholding
1st Feb 20221:00 pmRNSDirector/PDMR Shareholding
20th Jan 20222:45 pmRNSHolding(s) in Company
18th Jan 20221:56 pmRNSDirector/PDMR shareholding
14th Jan 202212:40 pmRNSDirector/PDMR Shareholding
14th Jan 20227:00 amRNSResults of Placing
13th Jan 20224:36 pmRNSProposed Placing of New Ordinary Shares
13th Jan 20224:35 pmRNSEUR100m acquisition of astragon

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.